Business Context and Reporting Period
Company: Colgate-Palmolive Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2005
Business Overview: The Company operates in two primary segments: Oral, Personal and Home Care (divided into North America, Latin America, Europe, and Asia/Africa) and Pet Nutrition (Hill's). The Company competes in over 200 countries and territories.
Key Financial Metrics
| Metric ($ Millions) | Q1 2005 | Q1 2004 |
|---|---|---|
| Net Sales | $2,743.0 | $2,513.5 |
| Gross Profit | $1,503.6 | $1,399.6 |
| Operating Profit | $492.6 | $531.3 |
| Net Income | $300.1 | $338.5 |
| Diluted EPS | $0.53 | $0.59 |
| Operating Cash Flow | $425.0 | $371.3 |
| Cash and Equivalents (End of Period) | $413.9 | $271.5 |
| Total Debt (Current + Long-term) | $3,756.8 | $3,675.1 |
Margins: Gross profit margin declined to 54.8% (from 55.7% in Q1 2004). Operating profit margin was 18.0% (down from 21.1%).
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9.0% year-over-year, driven by 7.0% unit volume growth and a 2.5% positive foreign exchange impact. This was partially offset by a 0.5% decrease in net selling prices due to increased promotional spending.
- Profitability Decline: Operating profit decreased 7.3% to $492.6 million. This decline was primarily due to a $49.7 million pre-tax charge related to the 2004 Restructuring Program, higher raw material and energy costs, and increased advertising spend.
- Net Income: Net income fell 11.3% to $300.1 million. The restructuring charge reduced net income by $44.6 million (after-tax).
- Segment Performance:
- Europe: Sales grew 13.0%, significantly aided by the GABA acquisition (contributing 11.0% to sales growth) and a stronger euro.
- Latin America: Sales grew 10.5% with volume gains across all countries in the region.
- North America: Sales grew 7.0%, with operating profit flat year-over-year due to higher costs offsetting volume gains.
- Asia/Africa: Sales grew 6.5%, but operating profit declined 3% due to increased commercial investment and raw material costs.
- Restructuring: The Company incurred $49.7 million in restructuring charges in Q1 2005 as part of a four-year program initiated in December 2004. Cumulative charges through Q1 2005 total $118.4 million.
Guidance, Outlook, and Risks
- Restructuring Outlook: The 2004 Restructuring Program is expected to result in cumulative pre-tax charges of $750-$900 million. Annual savings are projected to be $325-$400 million by 2008. Savings from Q1 projects are expected to begin later in 2005.
- Capital Expenditures: Expected to be approximately 4.0% of Net sales for the full year 2005.
- Dividends: The Company increased the annualized common stock dividend to $1.16 per share and the Series B Preference Stock dividend to $9.28 per share, effective Q2 2005.
- Share Repurchases: The Company repurchased 4.55 million shares under its publicly announced program in Q1 2005. Approximately 12 million shares remain available under the 20 million share authorization.
- Risks and Contingencies:
- Legal/Tax: Significant ongoing disputes with the IRS regarding expatriate executive compensation (potential tax impact ~$119 million) and Brazilian authorities regarding the 1995 Kolynos acquisition (potential fines/assessments ~$170 million). Management intends to defend these positions vigorously.
- Operational: Continued pressure from high raw material and energy costs, and a competitive marketplace.
- Regulatory: Uncertainty regarding the interpretation of the American Jobs Creation Act of 2004 (AJCA) concerning the repatriation of foreign earnings.
Investor Verification Checklist
- Restructuring Impact: Verify the timeline for realizing the projected $325-$400 million in annual savings and the final cumulative cost of the restructuring program.
- Cost Inflation: Monitor the trajectory of raw material and energy costs and their impact on gross margins in subsequent quarters.
- Legal Exposure: Track the status of the IRS audit and Brazilian Central Bank/Tax proceedings, as resolution could impact cash flows.
- Foreign Exchange: Assess the sustainability of sales growth given the significant contribution of favorable currency translation (2.5% globally, 6.0% in Europe) in Q1 2005.
- Debt Management: Review the Company's ability to refinance commercial paper and manage debt levels, particularly given the increased borrowing to finance the GABA acquisition.